» Articles » PMID: 18779631

Rituximab Therapy in a Patient with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia Associated with Chronic Lymphocytic Leukemia

Overview
Journal Ann Saudi Med
Specialty General Medicine
Date 2008 Sep 10
PMID 18779631
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.

Tandra P, Krishnamurthy J, Bhatt V, Newman K, Armitage J, Akhtari M Mediterr J Hematol Infect Dis. 2013; 5(1):e2013068.

PMID: 24363883 PMC: 3867225. DOI: 10.4084/MJHID.2013.068.

References
1.
Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S . Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia. Leukemia. 2002; 16(10):2092-5. DOI: 10.1038/sj.leu.2402676. View

2.
Leach M, Parsons R, Reilly J, Winfield D . Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders. Clin Lab Haematol. 2000; 22(3):175-8. DOI: 10.1046/j.1365-2257.2000.00305.x. View

3.
Fernandez M, Llopis I, Pastor E, Real E, Grau E . Immune thrombocytopenia induced by fludarabine successfully treated with rituximab. Haematologica. 2003; 88(2):ELT02. View

4.
Okamoto M, Nakano S, Namura K, Yamada N, Uchida R, Fuchida S . CD5-negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab. Am J Hematol. 2004; 77(4):413-5. DOI: 10.1002/ajh.20223. View

5.
Zaja F, Vianelli N, Sperotto A, De Vita S, Iacona I, Zaccaria A . B-cell compartment as the selective target for the treatment of immune thrombocytopenias. Haematologica. 2003; 88(5):538-46. View